First Turn Management »

Karuna Therapeutics Ord shares owned by First Turn Management

Quarter-by-quarter ownership of Karuna Therapeutics Ord shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Karuna Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Karuna Therapeutics Ord held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karuna Therapeutics Ord by First Turn Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $28M 87k 316.51

More positions owned by First Turn Management

Cytokinetics Com New (CYTK)
Cymabay Therapeutics
Vertex Pharmaceuticals Incorporated (VRTX)
Argenx Se Sponsored Adr (ARGX)
Xenon Pharmaceuticals (XENE)
Krystal Biotech (KRYS)
Legend Biotech Corp Sponsored Ads (LEGN)
Karuna Therapeutics Ord
Transmedics Group (TMDX)
Insulet Corporation (PODD)
Day One Biopharmaceuticals I (DAWN)
Mirum Pharmaceuticals (MIRM)
Verona Pharma Sponsored Ads (VRNA)
Dex (DXCM)
Axsome Therapeutics (AXSM)

View all positions for First Turn Management

Top funds holding Karuna Therapeutics Ord

Vanguard Group
T. Rowe Price Associates
Pentwater Capital Management
Wellington Management Company
UBS Group
Alliancebernstein
Norges Bank Investment Management
Balyasny Asset Management
First Light Asset Management
Citadel Advisors
Boxer Capital
Charles Schwab Investment Management
Alpine Associates Management
Avidity Partners Management
Goldman Sachs Group

View all funds holding Karuna Therapeutics Ord